Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bayonne
Clinical trial register · France

Clinical Trials in Bayonne, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9729 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
9729
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1030
Lead sponsors
across recruiting studies
Top sites
Paris 2848 Lyon 1397 Bordeaux 1393 Marseille 1290 Lille 1276

Trials with a site in Bayonne

187 of 9729 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Centre Hospitalier Universitaire de Saint Etienne
Phase 1/2
44
Amiens, Angers, Annecy, Argenteuil, Bayonne, Bordeaux, Brest, Caen
2026-12-01
Not yet open
University Hospital, Clermont-Ferrand
Phase 4
240
Amiens, Avignon, Bayonne, Clermont-Ferrand, La Roche-sur-Yon, Montpellier, Nancy, Nîmes
2026-12-01
Not yet open
The Lymphoma Academic Research Organisation
Phase 2
95
Lyon, Argenteuil, Avignon, Bayonne, Bordeaux, Cergy-Pontoise, Corbeil-Essonnes, Estaing
2026-12
Recruiting
Poitiers University Hospital
Not applicable
778
Angers, Bayonne, La Roche-sur-Yon, La Rochelle, Montpellier, Nancy, Poitiers, Rennes
2026-11-02
Not yet open
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
90
Bayonne
2026-11
Recruiting
University Hospital, Toulouse
Not applicable
120
Bayonne, Bron, Marseille, Toulouse
2026-10-21
Not yet open
Philippe ROUSSELOT
Phase 2
93
Aix-en-Provence, Amiens, Angers, Argenteuil, Avignon, Bayonne, Besançon, Bobigny
2026-09-01
Not yet open
French Innovative Leukemia Organisation
Phase 2
60
Angers, Bayonne, Besançon, Clamart, Créteil, Grenoble, Lille, Limoges
2026-09
Not yet open
University Hospital, Bordeaux
Phase 1/2
41
Bayonne, Pessac, Toulouse
2026-09
Recruiting
Skipping Hormone Therapy in Low-Risk Early Breast Cancer
NCT07661927Breast Cancer (Early Breast Cancer)
UNICANCER
Phase 2
700
Angers, Avignon, Bayeux, Bayonne, Bordeaux, Boulogne-sur-Mer, Brest, Briis-sous-Forges
2026-07-06
Recruiting
Janssen Research & Development, LLC
Phase 2
230
Argenteuil, Bayonne, La Tronche, Le Mans, Nantes, Quimper
2026-06-30
Recruiting
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
NCT07638553Alcohol Use Disorder, Depressive Sympotoms, Psilocybin
Centre Hospitalier Universitaire de Nīmes
Phase 3
172
Bayonne, Besançon, Bordeaux, Brest, Bron, Nantes, Nîmes, Saint-Priest
2026-06-30
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Auxerre, Avignon, Bayonne, Beauvais, Blois, Bobigny, Bordeaux, Bourg-en-Bresse
2026-06-26
Recruiting
Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
NCT07455942Squamous Cell Carcinoma of the Anal Canal, HPV-induced Cancer
Centre Hospitalier Intercommunal Creteil
Observational
300
Angers, Avignon, Bayonne, Beuvry, Château-Gontier, Cholet, Créteil, Épagny
2026-06-23
Recruiting
AstraZeneca
Phase 3
150
Angers, Bayonne, Bobigny, Caen, Chambray-lès-Tours, Grenoble, Montpellier, Nancy
2026-06-15
Recruiting
University Hospital, Bordeaux
Not applicable
300
Bayonne
2026-06-11
Recruiting
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase 3
320
Bayonne, Bordeaux, Brest, Créteil, Grenoble, Levallois-Perret, Lorient, Montpellier
2026-06-05
Not yet open
Central Hospital, Nancy, France
Phase 3
4,336
Annecy, Bayonne, Besançon, Brest, Colmar, Corbeil-Essonnes, Courbevoie, La Tronche
2026-06
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Bayonne, Bordeaux, Brest, Chambray-lès-Tours, Cholet, La Rochelle, Le Chesnay, Le Coudray
2026-05-11
Recruiting
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT07179276Sepsis - to Reduce Mortality in the Intensive Care Unit, Septic Shock
University Hospital, Clermont-Ferrand
Not applicable
750
Angers, Aurillac, Bayonne, Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Le Puy-en-Velay
2026-03-29
Recruiting
Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
NCT07299071Colonoscopy, Colorectal Neoplasms, Intestinal Polyps
University Hospital, Bordeaux
Not applicable
592
Bayonne, Brest, Carhaix-Plouguer, Charenton-le-Pont, Limoges, Marseille, Nantes, Nîmes
2026-03-13
Recruiting
Federation Francophone de Cancerologie Digestive
Not applicable
300
Poitiers, Albi, Amiens, Annecy, Aurillac, Bayeux, Bayonne, Beauvais
2026-03-10
Recruiting
C4 Therapeutics, Inc.
Phase 2
100
Bayonne, Lyon, Marseille, Rouen, Toulouse, Tours, Villejuif
2026-02-18
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
74
Angers, Arras, Auxerre, Bayeux, Bayonne, Beauvais, Besançon, Beuvry
2025-12-31
Recruiting
UNICANCER
Phase 3
3,902
Amiens, Angers, Argenteuil, Aurillac, Auxerre, Avignon, Bayonne, Beauvais
2025-12-18
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
324
Aurillac, Avignon, Bayeux, Bayonne, Bezannes, Bordeaux, Brest, Caen
2025-12-15
Recruiting
Withdrawal of Dupilumab in Severe Asthma
NCT06818019Severe Asthma
University Hospital, Toulouse
Phase 4
205
Toulouse, Amiens, Angers, Bayonne, Besançon, Brest, Caen, Cannes
2025-12-15
Recruiting
University Hospital, Bordeaux
Not applicable
300
Angers, Bayonne, Bordeaux, Brest, Créteil, La Roche-sur-Yon, Le Kremlin-Bicêtre, Libourne
2025-12-09
Recruiting
Autonomous Methadone Delivery System by Nurses
NCT07085377Opioid Use Disorder (OUD), Addictology
Hospices Civils de Lyon
Not applicable
182
Bayonne, Bordeaux, Brioude, Le Puy-en-Velay, Lyon, Strasbourg, Villeurbanne
2025-12-08
Recruiting
Glofitamab in Real Life
NCT06994169Large B-cell Lymphoma
The Lymphoma Academic Research Organisation
Observational
250
Argenteuil, Avignon, Bayonne, Besançon, Clamart, Créteil, Dijon, Dunkirk
2025-12-01
Not yet open
French Innovative Leukemia Organisation
Phase 2
102
Amiens, Angers, Annecy, Argenteuil, Bayonne, Besançon, Bordeaux, Caen
2025-12-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Bordeaux, Suresnes, Montpellier, La Tronche, Nancy, Angers, Bayonne, Pierre-Bénite
2025-11-26
Recruiting
Centre Hospitalier de la côte Basque
Observational
30
Bayonne
2025-11-22
Recruiting
Eli Lilly and Company
Phase 3
1,630
Angers, Bayonne, Besançon, Bordeaux, Brest, Lille, Limoges, Lyon Cedex08
2025-10-22
Recruiting
University Hospital, Clermont-Ferrand
Phase 2
95
Annecy, Amiens, Avignon, Bayonne, Besançon, Beuvry, Brest, Caen
2025-10-07
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Bayonne, Clermont-Ferrand, Créteil, Échirolles, Lille, Montfermeil, Montpellier, Nantes
2025-10-03
Active, closed
Janssen Research & Development, LLC
Phase 3
896
Bayonne, Clermont-Ferrand, Créteil, Échirolles, Lille, Limoges, Montfermeil, Montpellier
2025-10-01
Not yet open
University Hospital, Tours
Not applicable
80
Angers, Bayonne, Bordeaux, Chartres, Gradignan, La Roche-sur-Yon, Nantes, Orléans
2025-09-30
Recruiting
Pfizer
Phase 3
1,000
Bordeaux, Lyon Cedex08, Brest, Besançon, Reims, Bayonne, Pierre-Bénite, Villejuif
2025-09-28
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Angers, Annecy, Antony, Aurillac, Bayeux, Bayonne, Beauvais, Besançon
2025-08-31
Recruiting
UNICANCER
Phase 2
80
Amiens, Auxerre, Avignon, Bayonne, Beauvais, Beuvry, Blois, Boulogne-sur-Mer
2025-07-30
Active, closed
Nantes University Hospital
Phase 2
176
Amiens, Angers, Bayonne, Besançon, Caen, Clamart, Clermont-Ferrand, Dijon
2025-07-09
Recruiting
Intergroupe Francophone du Myelome
Phase 3
824
Amiens, Angers, Annecy, Argenteuil, Avignon, Bayonne, Besançon, Blois
2025-07-09
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Bordeaux, Lille, Saint-Herblain, Bayonne, Pierre-Bénite
2025-07-03
Recruiting
EG Labo
Observational
246
Amiens, Bayonne, Besançon, Brest, Montpellier, Nantes, Neuilly-sur-Seine, Pierre-Bénite
2025-06-02
Recruiting
Ruxolitinib Treatment in Inclusion Body Myositis
NCT06536166Inclusion Body Myositis, Sporadic
Assistance Publique - Hôpitaux de Paris
Phase 2
80
Angers, Bayonne, Besançon, Bordeaux, Brest, Bron, Caen, Créteil
2025-05-27
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Amiens, Angers, Bayonne, Besançon, Caen, Clamart, Clermont-Ferrand, Créteil
2025-05-05
Recruiting
Resilience
Phase 3
1,458
Aix-en-Provence, Aurillac, Bayonne, Caen, Clermont-Ferrand, La Tronche, Lille, Lyon
2025-04-01
Recruiting
Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa
NCT06738771Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial
Centre Hospitalier Régional d'Orléans
Observational
600
Amiens, Argenteuil, Bayonne, Besançon, Béthune, Bobigny, Bourgoin, Chambéry
2025-03-11
Recruiting
UNICANCER
Phase 2
220
Amiens, Avignon, Bayonne, Besançon, Bordeaux, Caen, Dijon, La Roche-sur-Yon
2025-03-11
Not yet open
Hopitaux Prives de Metz, Groupe UNEOS
Not applicable
154
Metz, Bayonne
2025-03-01
Active, closed
Sanofi
Observational
600
Aix-en-Provence, Amiens, Angers, Arès, Bayonne, Bezannes, Biarritz, Bordeaux
2025-02-04
Recruiting
UNICANCER
Phase 2
400
Amiens, Aurillac, Avignon, Bayeux, Bayonne, Besançon, Caen, Caluire-et-Cuire
2025-01-20
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
136
Bayonne, Marseille
2025-01-14
Recruiting
BioNTech SE
Phase 2/3
1,580
Angers, Bayonne, Bordeaux, Bron, Caen, Clermont-Ferrand, Créteil, La Tronche
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Bayonne, Bordeaux, Lille, Saint-Cloud, Rennes, Montpellier, Saint-Herblain, Angers
2025-01-06
Recruiting
UNICANCER
Phase 2
354
Amiens, Avignon, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Dijon, Levallois-Perret
2024-12-27
Recruiting
Hoffmann-La Roche
Phase 3
500
Amiens Cedex1, Bayonne, Besançon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand
2024-12-13
Active, closed
Genmab
Phase 3
191
Marseille, Bordeaux, Paris, Bayonne, Avignon, Villejuif, Angers, Boulogne-Billancourt
2024-11-25
Active, closed
Regeneron Pharmaceuticals
Phase 2
184
Rennes, Toulon, Bayonne, Grenoble, Montpellier, Paris
2024-11-18
Active, closed
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
NCT05720910Breast Cancer, Comorbidities and Coexisting Conditions, Lung Cancer, Colorectal Cancer
Institut Bergonié
Not applicable
720
Bayonne, Bordeaux, Dinan, La Roche-sur-Yon, Lyon, Mougins, Nice, Paris
2024-10-15
Recruiting
EIT Assessment of Overdistension in ARDS Patients in Prone Position
NCT06536543Acute Respiratory Distress Syndrome
University Hospital, Bordeaux
Observational
20
Bayonne, Pessac
2024-10-15
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Amgen
Phase 3
163
Bayonne, Bordeaux, Caen, Marseille, Paris, Toulon, Vantoux
2024-09-12
Recruiting
AstraZeneca
Phase 3
1,018
Bayonne, La Tronche, Lille, Montpellier, Saint-Cloud, Vandœuvre-lès-Nancy
2024-08-07
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Angers, Bayonne, Bordeaux, Caen, Dijon, Le Mans, Lille, Lyon
2024-07-31
Recruiting
French Innovative Leukemia Organisation
Observational
250
Amiens, Angers, Bayonne, Besançon, Clermont-Ferrand, Créteil, Dunkirk, Grenoble
2024-07-31
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
210
Bayonne, Bordeaux, La Rochelle, Les Sables-d'Olonne, Marseille, Montpellier, Nantes, Nice
2024-07-24
Active, closed
Nantes University Hospital
Phase 2
103
Bayonne, Caen, Dijon, La Roche-sur-Yon, Lille, Limoges, Lyon, Marseille
2024-06-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Nice, Bayonne, Guilherand-Granges, Lyon Cedex08, Clermont-Ferrand, Marseille, Caen, Dijon
2024-06-24
Recruiting
Evaluation of a Dimensional Adaptation of Good Psychiatric Management (GPM-extended) for the Treatment of Borderline Personality Disorder
NCT06913738Borderline Personality Disorder, Narcissism, Obsessive Compulsive Personality Disorder, Personality Disorder
AddiPsy
Not applicable
154
Bayonne, Lyon
2024-06-19
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Avignon, Bayonne, Besançon, Bordeaux, Cahors, Chambéry, Clermont-Ferrand, Créteil
2024-06-07
Recruiting
Institut Curie
Phase 3
300
Bayonne, Bordeaux, Caen, Dijon, Lille, Limoges, Lyon, Marseille
2024-05-27
Recruiting
CARE1 Pragmatic Clinical Trial
NCT06364631Metastatic Kidney Cancer, Metastatic Kidney Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
1,250
Angers, Avignon, Bayonne, Besançon, Bordeaux, Caen, Chalon-sur-Saône, Clermont-Ferrand
2024-04-12
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
Alexion Pharmaceuticals, Inc.
Phase 3
584
Amiens, Bayonne, Brest, Chambéry, Le Kremlin-Bicêtre, Marseille, Nantes, Paris
2024-03-29
Recruiting
French Innovative Leukemia Organisation
Phase 2
40
Amiens, Angers, Bayonne, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon
2024-03-21
Recruiting
AstraZeneca
Phase 3
5,250
Aix-en-Provence, Aurillac, Bayonne, Biarritz, Blois, Brest, Cannes, Cherbourg
2024-02-21
Recruiting
Federation Francophone de Cancerologie Digestive
Observational
600
Bayonne, Beauvais, Besançon, Boujan-sur-Libron, Boulogne-sur-Mer, Chambéry, Cholet, Compiègne
2024-02-12
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Not applicable
300
Angers, Bayonne, Boulogne, Bron, Caen, Clermont-Ferrand, Colmar, Créteil
2024-01-22
Recruiting
University Hospital, Bordeaux
Not applicable
256
Bayonne, Besançon, Brest, Caen, Clermont-Ferrand, Colombes, La Tronche, Lille
2024-01-15
Recruiting
EWALL-PH OBSERVARTORY 2022
NCT07684131Acute Lymphoblastic Leukemia
Versailles Hospital
Observational
100
Amiens, Angers, Bayonne, Bordeaux, Clamart, Clermont-Ferrand, Corbeil-Essonnes, Grenoble
2024-01-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Lille, Strasbourg, Nîmes, Rennes, Clermont-Ferrand, Bayonne, Villejuif, Paris
2023-12-31
Active, closed
University Hospital, Lille
Phase 2
74
Amiens, Angers, Avignon, Bayonne, Besançon, Caen, Dijon, La Tronche
2023-12-21
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Bayonne, Beuvry, Boulogne-sur-Mer, Bron, Calais, Chambray-lès-Tours, Dechy, Dijon
2023-12-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Marseille, Montpellier, Limoges, Nancy, Bayonne, Villefranche-sur-Saône, Amiens, Poitiers
2023-12-15
Active, closed
Poitiers University Hospital
Phase 3
170
Angers, Annecy, Bayonne, Brest, Brive-la-Gaillarde, Chambéry, Créteil, La Rochelle
2023-12-01
Active, closed
AstraZeneca
Phase 3
1,898
Angers, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Créteil, Lyon, Montpellier
2023-11-21
Recruiting
Amgen
Phase 3
750
Bayonne, Besançon, Boulogne-Billancourt, Brest, Caen, Chambéry, Créteil, La Roche-sur-Yon
2023-11-16
Active, closed
AstraZeneca
Phase 3
1,902
Avignon, Bayonne, Caen, Clermont-Ferrand, Limoges, Marseille, Montpellier, Nice
2023-11-14
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Amiens, Antony, Arras, Avignon, Bayonne, Besançon, Bordeaux, Bourg-en-Bresse
2023-10-24
Active, closed
AstraZeneca
Phase 3
895
Angers, Avignon, Bayonne, Bordeaux, Caen, Lille, Limoges, Marseille
2023-10-24
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
387
Angers, Bayonne, Bordeaux, Brest, Clermont-Ferrand, Grenoble, Lille, Limoges
2023-10-17
Active, closed
Intergroupe Francophone du Myelome
Observational
200
Amiens, Annecy, Argenteuil, Bayonne, Besançon, Bordeaux, Brive-la-Gaillarde, Caen
2023-09-19
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Nancy, Amiens, Avignon, Bayonne, Besançon, Bordeaux, Clermont-Ferrand, Créteil
2023-09-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
792
Amiens, Bayonne, Besançon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand
2023-07-07
Recruiting
University Hospital, Bordeaux
Observational
120
Angers, Bayonne, Bordeaux, Brest, Dax, Libourne, Mont-de-Marsan, Pessac
2023-06-19
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
156
Amiens, Angers, Avignon, Bayonne, Besançon, Bordeaux, Boulogne, Caen
2023-04-26
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Angers, Bayonne, Béziers, Brest, Bron, Corbeil-Essonnes, Créteil, Dijon
2023-04-11
Active, closed
UNICANCER
Phase 2
100
Aix-en-Provence, Avignon, Bayonne, Caen, Clermont-Ferrand, Créteil, Dijon, Lille
2023-03-24
Active, closed
Bristol-Myers Squibb
Phase 3
579
Toulouse, Chambray-lès-Tours, Lille, Nantes, Villejuif, Amiens, Bayonne, Bordeaux
2023-03-06
Active, closed
AlgoTherapeutix
Phase 2
276
Bayonne, Bordeaux, Montpellier, Paris, Poitiers, Reims, Strasbourg, Suresnes
2023-02-28
Active, closed
Sandoz
Observational
562
Amiens, Auxerre, Bayonne, Beauvais, Brest, Caen, Castelnau-le-Lez, Clermont-Ferrand
2023-02-16
Active, closed
University Hospital, Bordeaux
Phase 3
22
Bayonne, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Grenoble, Limoges
2023-01-23
Recruiting
Low Impact Laparoscopic in Colorectal Resection - PAROS2
NCT04742881Malignant or Benign Pathology
University Hospital, Bordeaux
Not applicable
148
Bayonne, Bordeaux, Libourne
2022-12-14
Active, closed
AstraZeneca
Observational
254
Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Clermont-Ferrand, Créteil, Dijon
2022-11-14
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Cholet, Créteil
2022-10-27
Active, closed
Eli Lilly and Company
Phase 3
8,000
Avignon, Bayonne, Besançon, Bordeaux, Brest, Clermont-Ferrand, Créteil, La Chaussée-Saint-Victor
2022-10-04
Recruiting
SPINEVISION SAS
Observational
330
Bayonne, Bruges, Saint-Etienne
2022-09-22
Recruiting
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
NCT05198661Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
Hospices Civils de Lyon
Not applicable
3,500
Pointe à Pitre, Aix-en-Provence, Amiens, Angers, Annecy, Avignon, Bayonne, Besançon
2022-08-02
Recruiting
Hospices Civils de Lyon
Not applicable
204
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Chambéry, Clermont-Ferrand
2022-08-01
Active, closed
Hoffmann-La Roche
Phase 3
922
Avignon, Bayonne, Besançon, Bordeaux, Grenoble, La Roche-sur-Yon, Lyon, Paris
2022-07-18
Recruiting
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
NCT05198960Polycythemia Vera, Essential Thrombocythemia, Prefibrotic/Early Primary Myelofibrosis, JAK2 V617F
University Hospital, Brest
Phase 3
1,308
Angers, Annecy, Argenteuil, Avignon, Bayonne, Béziers, Bordeaux, Brest
2022-07-13
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
10,000
Bayonne, Bligny, Bordeaux, Corbeil-Essonnes, Épagny, Grenoble, La Réunion, Melun
2022-06-29
Recruiting
University Hospital, Bordeaux
Phase 2/3
90
Bayonne, Bordeaux, Brest, Grenoble, Libourne, Mont-de-Marsan, Paris, Pau
2022-06-22
Recruiting
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
NCT04672733Chronic Inflammatory Demyelinating Polyneuropathy
CSL Behring
Observational
100
Amiens, Angers, Aubagne, Bayonne, Bordeaux, Brest, Créteil, Le Kremlin-Bicêtre
2022-06-10
Active, closed
French Innovative Leukemia Organisation
Phase 2
134
Angers, Annecy, Avignon, Bayonne, Besançon, Béziers, Clermont-Ferrand, Grenoble
2022-05-25
Recruiting
Groupe Francophone des Myelodysplasies
Phase 1/2
150
Amiens, Angers, Argenteuil, Avignon, Bayonne, Bobigny, Cesson-Sévigné, Compiègne
2022-05-18
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
1,100
Avignon, Bayonne, Besançon, Blois, Caen, Cholet, Clermont-Ferrand, Dijon
2022-05-03
Recruiting
UNICANCER
Phase 3
300
Avignon, Bayonne, Besançon, Beuvry, Bordeaux, Brest, Caen, Chambéry
2022-04-19
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
180
Amiens, Aurillac, Bayonne, Bordeaux, Chambéry, Clermont-Ferrand, Grenoble, Issoire
2022-03-21
Active, closed
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
NCT05078047Lung Cancer Metastatic, Renal Cell Carcinoma, Head and Neck Cancer, Triple Negative Breast Cancer
UNICANCER
Phase 3
646
Angers, Avignon, Bayonne, Bordeaux, Boulogne-sur-Mer, Caen, Clermont-Ferrand, Créteil
2022-03-08
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 3
72
Amiens, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Lille, Lyon, Marseille
2022-03-08
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
210
Angers, Avignon, Bayonne, Besançon, Brest, Caen, Clermont-Ferrand, Créteil
2022-01-24
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Bayonne, Besançon, Colombes, Nantes, Nice, Paris, Pierre-Bénite, Reims
2022-01-19
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
71
Avignon, Bayonne, Besançon, Bordeaux, Corbeil-Essonnes, La Roche-sur-Yon, Lille, Limoges
2021-12-20
Active, closed
Nantes University Hospital
Phase 2
75
Annecy, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Dijon, La Roche-sur-Yon, Lille
2021-12-14
Active, closed
Intergroupe Francophone du Myelome
Phase 3
791
Amiens, Angers, Argenteuil, Avignon, Bayonne, Besançon, Blois, Bobigny
2021-12-08
Recruiting
Centre Hospitalier Departemental Vendee
Not applicable
526
Bayonne, La Roche-sur-Yon, Le Puy-en-Velay, Nantes, Orléans, Rennes, Saint-Herblain
2021-12-07
Active, closed
Gilead Sciences
Phase 3
603
Avignon, Bayonne, Boulogne-Billancourt, Caen, Calvados, Chauny, Clermont-Ferrand, Créteil
2021-11-17
Active, closed
French Innovative Leukemia Organisation
Phase 2
160
Angers, Argenteuil, Avignon, Bayonne, Bobigny, Cesson-Sévigné, Clermont-Ferrand, Corbeil-Essonnes
2021-10-18
Active, closed
Study of Lacutamab in Peripheral T-cell Lymphoma
NCT04984837Peripheral T Cell Lymphoma, Relapse/Recurrence
The Lymphoma Academic Research Organisation
Phase 2
49
Amiens, Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand
2021-10-05
Active, closed
Eli Lilly and Company
Phase 3
874
Strasbourg, La Chaussée-Saint-Victor, Besançon, Saint-Cloud, Montpellier, Le Mans, Bayonne, Paris
2021-10-04
Active, closed
AstraZeneca
Phase 3
712
Amiens, Bayonne, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nice
2021-08-05
Active, closed
ARCAGY/ GINECO GROUP
Phase 2
185
Angers, Avignon, Bayonne, Besançon, Bordeaux, Caen, Chambray-lès-Tours, Cholet
2021-08-05
Active, closed
University Hospital, Bordeaux
Phase 3
160
Bayonne, Belfort, Bobigny, Bordeaux, Brest, Caluire-et-Cuire, Clermont-Ferrand, Dax
2021-07-15
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
141
Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon
2021-06-11
Active, closed
Pfizer
Phase 3
599
Brest, Le Mans, Angers, Bayonne, Lille, Lyon, Paris, Pierre-Bénite
2021-05-12
Active, closed
AstraZeneca
Observational
274
Abbeville, Aix-en-Provence, Angers, Antibes, Avignon, Bastia, Bayonne, Bordeaux
2021-05-12
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
54
Aix-en-Provence, Angers, Annecy, Antony, Avignon, Bayonne, Bordeaux, Boulogne
2021-03-19
Active, closed
Genmab
Phase 3
483
Amiens, Bayonne, Brest, Caen, La Rochelle, Limoges, Lyon, Marseille
2021-01-13
Active, closed
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
NCT04446962Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Primary
Institut Curie
Phase 1/2
118
Amiens, Angers, Bayonne, Besançon, Bordeaux, Caen, Clermont-Ferrand, Colmar
2020-10-30
Active, closed
Hoffmann-La Roche
Phase 3
992
Angers, Bayonne, La Roche-sur-Yon, Montpellier, Poitiers, Reims, Rennes, Saint-Priest-en-Jarez
2020-10-09
Active, closed
University Hospital, Bordeaux
Not applicable
500
Bayonne, Bordeaux
2020-10-01
Active, closed
BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
NCT04555174Coronary Artery Disease, Myocardial Ischemia
Biotronik AG
Observational
872
Agen, Aix-en-Provence, Antibes, Bastia, Bayonne, Bourg-en-Bresse, Caen, Clermont-Ferrand
2020-09-25
Active, closed
Razor Genomics
Not applicable
420
Bordeaux, Rouen, Angers, Bayonne, Besançon, Boulogne, Clamart, Créteil
2020-09-11
Active, closed
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
NCT04258137Colorectal Cancer, Non Small Cell Lung Cancer
Institut Bergonié
Not applicable
332
Bayonne, Bordeaux, Brest, Pau
2020-09-04
Active, closed
Sanofi
Phase 3
337
Ars-Laquenexy, Bayonne, Grenoble, La Roche-sur-Yon, Lille, Paris, Poitiers, Rennes
2020-06-16
Recruiting
University Hospital, Limoges
Observational
1,180
Agen, Amiens, Auxerre, Bayonne, Besançon, Bordeaux, Brest, Bron
2020-03-13
Active, closed
Pfizer
Phase 3
1,068
Antony, Bayonne, Bordeaux, Brest, Limoges, Nancy, Paris, Strasbourg
2019-12-30
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Amiens, Angers, Argenteuil, Bayonne, Besançon, Bobigny, Chesnay, Clamart
2019-12-20
Active, closed
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
NCT04602091Rheumatoid Arthritis, Inflammatory Rheumatism, Psoriatic Arthritis, Spondyloarthritis
Societe Francaise de Rhumatologie
Observational
2,300
Antibes, Bayonne, Belfort, Besançon, Bobigny, Bordeaux, Bourg-en-Bresse, Brest
2019-10-08
Recruiting
Centre Hospitalier de PAU
Observational
1,200
Annecy, Bayonne, Bobigny, Bordeaux, Chalon-sur-Saône, Chambéry, Clermont-Ferrand, Créteil
2019-09-20
Active, closed
Bristol-Myers Squibb
Phase 3
839
Limoges, Lille, Bayonne, Besançon, Lyon, Marseille, Montpellier, Nantes
2019-08-05
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 3
510
Abbeville, Aix-en-Provence, Ambilly, Ars-Laquenexy, Auxerre, Avignon, Bayonne, Besançon
2019-07-23
Active, closed
French Innovative Leukemia Organisation
Phase 2
82
Amiens, Angers, Annecy, Bayonne, Besançon, Béziers, Blois, Bordeaux
2019-05-22
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
Groupe Francophone des Myelodysplasies
Phase 2
68
Angers, Bayonne, Belfort, Caen, Grenoble, Le Mans, Limoges, Lyon
2019-05-14
Active, closed
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast
NCT03878342DCIS, Breast Cancer, Low Risk DCIS, Breast Conserving Surgery
UNICANCER
Not applicable
295
Angers, Avignon, Bayonne, Bordeaux, Caen, Cherbourg, Clermont-Ferrand, Créteil
2019-05-10
Active, closed
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
NCT03744390Myelodysplastic Syndromes, Leukemia Acute Myeloid
Groupe Francophone des Myelodysplasies
Phase 2
68
Versailles, Montpellier, Angers, Argenteuil, Bayonne, Bordeaux, Caen, Créteil
2019-04-02
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Amiens, Angers, Argenteuil, Bayonne, Besançon, Bobigny, Chambéry, Chesnay
2019-03-01
Active, closed
Hoffmann-La Roche
Phase 3
927
Bayonne, Bordeaux, Bron, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier
2018-05-28
Recruiting
Centre Hospitalier Henri Laborit
Observational
2,000
Angers, Anglet, Avignon, Bayonne, Bégard, Caen, Clermont-Ferrand, Dijon
2018-04-24
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Amiens, Bayonne, Besançon, Caen, Chambray Les Tours Centre, Créteil, Grenoble, Lille
2018-04-13
Active, closed
Groupe Francophone des Myelodysplasies
Phase 3
124
Amiens, Angers, Avignon, Bayonne, Belfort, Besançon, Bobigny, Brest
2018-03-26
Active, closed
Pfizer
Phase 3
1,054
Le Mans, Bayonne, Bordeaux, La Roche-sur-Yon, Lyon, Montpellier, Paris, Strasbourg
2017-12-18
Active, closed
Sanofi
Phase 3
475
Bayonne, Caen, Dijon, La Roche-sur-Yon, Lille, Nantes, Paris, Pessac
2017-12-07
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Amiens, Arras, Bayonne, Beuvry, Grenoble, Lyon, Nantes, Paris
2017-09-25
Active, closed
Medtronic
Observational
1,092
Avignon, Bayonne, Brest, Caen, Clermont-Ferrand, Dijon, La Rochelle, Marseille
2017-08-21
Active, closed
University Hospital, Bordeaux
Observational
7,500
Agen, Angoulême, Bayonne, Bordeaux, Dax, Jonzac, La Teste-de-Buch, Libourne
2017-07-18
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
348
Angers, Antony, Avignon, Bayonne, Beauvais, Bordeaux, Caluire-et-Cuire, Challans
2016-12
Recruiting
Institut Bergonié
Not applicable
10,000
Bayonne, Bordeaux, Pau, Rennes
2015-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Amiens, Angers, Avignon, Bayonne, Besançon, Bordeaux, Brest, Dijon
2015-11-19
Active, closed
Medtronic
Observational
3,100
Annecy, Bayonne, Bordeaux, Brest, Chambray-lès-Tours, Clermont-Ferrand, Grenoble, Lille
2015-07
Recruiting
French Innovative Leukemia Organisation
Observational
1,000
Angers, Annecy, Avignon, Bayonne, Besançon, Brest, Clermont-Ferrand, Colmar
2015-01-06
Active, closed
UNICANCER
Phase 3
1,173
Albi, Angers, Annecy, Avignon, Avranches, Bayonne, Besançon, Beuvry
2013-11-13
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Amiens, Angers, Bayonne, Bordeaux, Brest, Bron, Caen, Chambéry
2013-03-18
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI)
Phase 3
5,018
Angers, Auch, Avignon, Bayonne, Beauvais, Blois, Bordeaux, Brest
2011-02-28
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1,649
Ambilly, Annecy, Aulnay-sous-Bois, Avignon, Bayonne, Besançon, Béziers, Bordeaux
1998-10
Recruiting
Medtronic
Observational
20,000
Avignon, Bayonne, Brest, Caen, Chambray-lès-Tours, Clermont-Ferrand, Dijon, La Rochelle
1983-01
Rows per page Showing 1–187 of 187
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-france/city/bayonne

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,729 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 187 of those studies with a site in Bayonne.

How many clinical trials are recruiting in Bayonne?

91 of the 187 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 13 have not yet opened recruitment, 83 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bayonne), 187 studies
PhaseStudiesRecruitingShare
Phase 3803442.8%
Phase 2371019.8%
Observational291915.5%
Not applicable282015%
Phase 1/2633.2%
Phase 2/3542.7%
Phase 4211.1%

Most active sponsors

Lead sponsors with the most studies (Bayonne)
Lead sponsorStudiesRecruiting
University Hospital, Bordeaux138
UNICANCER128
AstraZeneca93
French Innovative Leukemia Organisation83
The Lymphoma Academic Research Organisation82
Hoffmann-La Roche73
Federation Francophone de Cancerologie Digestive64
Janssen Research & Development, LLC62
Pfizer62
European Organisation for Research and Treatment of Cancer - EORTC52
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.